Macleods Pharmaceuticals Limited Moxifloxacin Export Data — India (DGFT 2022–2026)

Name: Macleods Pharmaceuticals Limited Moxifloxacin Export Records India — #9 Exporter, 20 Shipments, $656.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

Macleods Pharmaceuticals Limited — Moxifloxacin Exporter #9 | $656.3K Trade Value | TransData Nexus | TransData Nexus

Macleods Pharmaceuticals Limited — Moxifloxacin Exporter Profile

Indian Pharmaceutical Exporter · #9 for Moxifloxacin · $656.3K export value · DGFT Verified

Macleods Pharmaceuticals Limited is the #9 Indian exporter of Moxifloxacin with $656.3K in export value and 20 verified shipments. Macleods Pharmaceuticals Limited holds a 2.0% market share in Moxifloxacin exports across 10 countries. The company exports 64 pharmaceutical products worth $589.8M across 20 therapeutic categories.

Macleods Pharmaceuticals Limited — Moxifloxacin Export Profile: Buyers & Destinations

Macleods Pharmaceuticals Limited Moxifloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does Macleods Pharmaceuticals Limited Export Moxifloxacin?

Country	Value	Shipments	Share
NIGERIA	$200.0K	4	17.9%
SOUTH AFRICA	$182.4K	13	16.3%
PHILIPPINES	$150.0K	3	13.4%
NETHERLANDS	$147.3K	4	13.2%
UNITED STATES

Who Are the Top Buyers of Moxifloxacin from Macleods Pharmaceuticals Limited?

Buyer	Country	Value	Orders
MACLEODS PHARMACEUTICALS SA	SOUTH AFRICA	$148.1K	12
CLINICAL RESEARCH PRODUCT	UNITED STATES	$100.0K	2
DEPARTMENT OF HEALTH - -PHILIPPINES	PHILIPPINES	$100.0K	2
NATIONAL TUBERCULOSIS AND LEPROSY CONTROL	NIGERIA	$100.0K	2
NATIONAL TUBERCULOSIS AND LEPROSY	NIGERIA	$100.0K	2
I SOLUTIONS	NETHERLANDS	$100.0K	2
INMA PHARMA FOR IMPORT AND	YEMEN, DEMOCRATIC	$85.9K	3
MACLEODS PHARMACEUTICAL LIMITED LLC	UKRAINE	$50.0K	1
BRANCH CO MACLEODS PHARMACEUTI CALS LTD	KAZAKHSTAN	$50.0K	1
BRANCH COMPANY MACLEODS PHARMACEUTI	KAZAKISTAN	$50.0K	1

Macleods Pharmaceuticals Limited supplies Moxifloxacin to 22 buyers globally. The largest buyer is MACLEODS PHARMACEUTICALS SA (SOUTH AFRICA), followed by CLINICAL RESEARCH PRODUCT (UNITED STATES) and DEPARTMENT OF HEALTH - -PHILIPPINES (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Moxifloxacin Formulations Does Macleods Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES MOXIFLOXACIN HYDROCHLORIDE TABLETS400 mg	$237.7K	11
MOXIFLOXACIN 400MG TABS BNO:BMC32202A MF	$100.0K	2
MOXIMAC MOXIFLOXACIN HCL TABLETS 400MG B	$50.0K	1
MOXIFLOXACIN 400MG TABS. 10X10S 3650	$50.0K	1
MOXIFLOXACIN HYDROCHLORIDE 400MG TABS.	$50.0K	1
MOXIFLOXACIN 400 MG TABLETS. 10X10'S 6466 PACK	$50.0K	1
MOXIFLOXACIN HYDROCHLORIDE 400 MG TABLETS. 10X10'S 6466 PACK	$50.0K	1
MOXIFLOXACIN HYDROCHLORIDE 400MG TABLETS. (10X10'S) (2187 PACK)	$50.0K	1
MOXIFLOXACIN HYDROCHLORIDE 400 MG TABLETS. (10X10'S) (6466 PACK)	$50.0K	1
MOXIFLOXACIN HYDROCHLORIDE TABLETS 400 MG(12004 PACK,SIZE:10x10)(BATCH NO:14242850A,14242851A Mfg Dt:11/24 Exp Dt:10/29*	$50.0K	1

Macleods Pharmaceuticals Limited exports 33 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES MOXIFLOXACIN HY with 11 shipments worth $237.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Macleods Pharmaceuticals Limited Compare to Nearest Moxifloxacin Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	AUROLAB TRUST	$806.3K	192	46	$4.2K
8	ALEMBIC PHARMACEUTICALS LIMITED	$683.8K	25	1	$27.4K
9	MACLEODS PHARMACEUTICALS LIMITED ★	$656.3K	20	10	$32.8K
10	MANKIND PHARMA LIMITED	$452.0K	11	2	$41.1K
11	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$401.3K	15	6	$26.8K

Macleods Pharmaceuticals Limited ranks #9 among 336 Indian Moxifloxacin exporters. Average shipment value of $32.8K compared to the market average of $42.4K. The closest competitors by value are AUROLAB TRUST and ALEMBIC PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Moxifloxacin Exports?

Port	Shipments	% Share
SAHAR AIR	311	12.9%
SAHAR AIR CARGO ACC (INBOM4)	263	10.9%
DELHI AIR CARGO ACC (INDEL4)	152	6.3%
DELHI AIR	132	5.5%
NHAVA SHEVA SEA (INNSA1)	126	5.2%
Bombay Air	119	4.9%
CHENNAI AIR	111	4.6%
CHENNAI AIR CARGO ACC (INMAA4)	93	3.9%

Geopolitical & Trade Policy Impact on Macleods Pharmaceuticals Limited's Moxifloxacin Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Macleods Pharmaceuticals. The Israel-Iran tensions have escalated security risks in the Red Sea and Strait of Hormuz, leading to increased shipping costs and extended transit times. Major carriers have rerouted vessels around the Cape of Good Hope, adding 10–20 days to shipments and raising freight rates by 40–50% on key India–Europe routes. (livemint.com)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. However, potential U.S. tariffs on Indian pharmaceutical imports pose a significant risk. A 25% tariff could render many low-margin generic drugs unprofitable, compelling companies to scale back operations or exit certain product segments, thereby exacerbating drug shortages in the U.S. (cfo.economictimes.indiatimes.com)

The recent India–European Union Free Trade Agreement, signed in January 2026, offers a favorable development by eliminating tariffs on most pharmaceutical products. This agreement is expected to enhance the competitiveness of Indian exporters in the EU market, providing a counterbalance to challenges in other regions. (en.wikipedia.org)

Macleods Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a cornerstone for Indian pharmaceutical exporters. Macleods Pharmaceuticals' recent recalls in the U.S. market, including the Famciclovir tablet recall due to contamination, highlight the critical need for stringent adherence to Good Manufacturing Practices (GMP). Such incidents can tarnish a company's reputation and impede market access. (pharma.economictimes.indiatimes.com)

The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates robust serialization and traceability measures. Indian exporters must invest in advanced compliance systems to meet these requirements, ensuring product integrity and sustaining export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Macleods Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 47 individual customs records matching Macleods Pharmaceuticals Limited exporting Moxifloxacin, covering 33 formulations to 19 countries via 22 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 731+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Moxifloxacin

Moxifloxacin

Macleods Pharmaceuticals Limited — Moxifloxacin Exporter Profile

Macleods Pharmaceuticals Limited — Moxifloxacin Export Profile: Buyers & Destinations

Where Does Macleods Pharmaceuticals Limited Export Moxifloxacin?

Who Are the Top Buyers of Moxifloxacin from Macleods Pharmaceuticals Limited?

What Is India's Total Moxifloxacin Export Value and How Much Does Macleods Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Macleods Pharmaceuticals Limited's Moxifloxacin Exports?

How Does Macleods Pharmaceuticals Limited Compare to Other Indian Moxifloxacin Exporters?

What Moxifloxacin Formulations Does Macleods Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Moxifloxacin to Key Markets

Nigeria — NAFDAC

South Africa — SAHPRA

How Does Macleods Pharmaceuticals Limited Compare to Nearest Moxifloxacin Exporters?

Which Indian Ports Ship Moxifloxacin Exports?

Geopolitical & Trade Policy Impact on Macleods Pharmaceuticals Limited's Moxifloxacin Exports

Macleods Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Macleods Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Moxifloxacin Export Data from Macleods Pharmaceuticals Limited

Moxifloxacin Stats

Company Overview

Top Products by Macleods Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source